Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

22 Oct 2021 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated October 22, 2021 titled ‘Zydus announces ‘first patient’ randomised in EVIDENCES-X TM Phase II(b) clinical trial of Saroglitazar Mg in NASH’.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..